Skip to main content

Advertisement

Log in

Circ-IGF1R Affects the Progression of Colorectal Cancer by Activating the miR-362-5p/HMGB3-Mediated Wnt/β-Catenin Signal Pathway

  • Original Article
  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the role of circRNA insulin growth factor 1 receptor (circ-IGF1R) in colorectal cancer (CRC). Glycolytic metabolism was analyzed by glucose uptake and lactate production using the corresponding kits. The protein levels were determined using Western blot. The effect of circ-IGF1R on CRC in vivo was explored by xenograft experiment in mice. Circ-IGF1R was up-regulated in CRC tissues and cells. Knockdown of circ-IGF1R inhibited proliferation, migration, invasion and glycolysis but induced apoptosis of CRC cells. Circ-IGF1R interacted with miR-362-5p and miR-362-5p inhibitor attenuated the anti-tumor effects of circ-IGF1R downregulation on CRC cells. HMGB3 acted as a downstream target for miR-362-5p, and circ-IGF1R facilitated the malignant behaviors of CRC cells by regulating HMGB3. Circ-IGF1R activated the Wnt/β-catenin pathway via targeting miR-362-5p/HMGB3 axis. Tumor growth in vivo was reduced after knockdown of circ-IGF1R. Circ-IGF1R might be a novel biomolecular target for CRC diagnosis and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data Availability

The analyzed data sets generated during the present study are available from the corresponding author on reasonable request.

Abbreviations

CRC:

Colorectal cancer

circRNAs:

Circular RNAs

pre-mRNAs:

Precursor mRNAs

circ-IGF1R:

Circular RNA insulin growth factor 1 receptor

HCC:

Hepatocellular carcinoma

miRNAs:

MicroRNAs

TFR1:

Transferrin receptor 1

HMGB3:

High mobility group-box 3

References

Download references

Acknowledgements

Not applicable.

Funding

No funding was received.

Author information

Authors and Affiliations

Authors

Contributions

XZ and WB: conceptualization and methodology. WB, JW and BJ: formal analysis and data curation. SG and XZ: validation and investigation. SG, XZ and WB: writing—original draft preparation and writing—review and editing. All authors: approval of final manuscript.

Corresponding author

Correspondence to Sheng Gao.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical Approval

The present study was approved by the ethical review committee of Shanxi provincial Cancer Hospital. Written informed consent was obtained from all enrolled patients.

Consent for Publication

Patients agree to participate in this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, S., Zhang, X., Bai, W. et al. Circ-IGF1R Affects the Progression of Colorectal Cancer by Activating the miR-362-5p/HMGB3-Mediated Wnt/β-Catenin Signal Pathway. Biochem Genet 61, 1210–1229 (2023). https://doi.org/10.1007/s10528-022-10316-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10528-022-10316-2

Keywords

Navigation